Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 37Neoplasms 3Neoplasm Metastasis 3Breast Diseases 3Neoplasms by Site 2Triple Negative Breast Neoplasms 1Skin Diseases 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Breast Neoplasm Female 1Breast Cancer Female 1Advanced Breast Carcinoma 1

Interventions

Tamoxifen 2pyrotinib 1exemestane 1abemaciclib 1Surgical Procedures, Operative 1Radiotherapy 1Radiation Dose Hypofractionation 1Mammaplasty 1Letrozole 1Drug Therapy 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Breast Cancer Female × Anastrozole × Clear all
NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting
123 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡